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Abstract
Aim: To assess volumetric tissue changes at peri-implantitis sites following combined 
surgical therapy of peri-implantitis over a 6-month follow-up period.
Materials and Methods: Twenty patients (n = 28 implants) diagnosed with peri-im-
plantitis underwent access flap surgery, implantoplasty at supracrestally or bucally 
exposed implant surfaces and augmentation at intra-bony components using a natu-
ral bone mineral and application of a native collagen membrane during clinical routine 
treatments. The peri-implant region of interest (ROI) was intra-orally scanned pre-
operatively (S0), and after 1 (S1) and 6 (S2) months following surgical therapy. Digital 
files were converted to standard tessellation language (STL) format for superimposi-
tion and assessment of peri-implant volumetric variations between time points. The 
change in thickness was assessed at a standardized ROI, subdivided into three equi-
distant sections (i.e. marginal, medial and apical). Peri-implant soft tissue contour area 
(STCA) (mm2) and its corresponding contraction rates (%) were also assessed.
Results: Peri-implant tissues revealed a mean thickness change (loss) of −0.11 and 
−0.28 mm at 1 and 6 months. S0 to S1 volumetric variations pointed to a thickness 
change of −0.46, 0.08 and 0.4 mm at marginal, medial and apical regions, respec-
tively. S0 to S2 analysis exhibited corresponding thickness changes of −0.61, −0.25 
and −0.09 mm, respectively. The thickness differences between the areas were sta-
tistically significant at both time periods. The mean peri-implant STCA totalled to 
189.2, 175 and 158.9 mm2 at S0, S1 and S2, showing a significant STCA contraction 
rate of 7.9% from S0 to S1 and of 18.5% from S0 to S2. Linear regression analysis 
revealed a significant association between the pre-operative width of keratinized 
mucosa (KM) and STCA contraction rate.
Conclusions: The peri-implant mucosa undergoes considerable volumetric changes 
after combined surgical therapy. However, tissue contraction appears to be influ-
enced by the width of KM.
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1  | INTRODUC TION
Peri-implantitis is defined as a biofilm-associated pathological 
condition that features an inflammatory lesion in the peri-implant 
mucosa and a loss of the implant supportive bone (Berglundh 
et al., 2018; Schwarz, Derks, Monje, & Wang, 2018). Non-surgical 
treatment of peri-implantitis was not effective to prevent disease 
progression, whereas access flap surgery had a marked effect on 
further bone loss (Karlsson et al., 2019). Adjunctive resective (i.e. 
implantoplasty), augmentative (i.e. bone fillers, autogenous grafts 
with or without guided bone regeneration) or combined (i.e. implan-
toplasty + augmentative) measures were also shown to be effective 
on the long term; however, their potential benefit over conventional 
surgical therapy is yet to be determined (Bianchini et al., 2019; 
Renvert, Polyzois, & Claffey, 2012; Roccuzzo, Bonino, Bonino, & 
Dalmasso, 2011; Romeo, Lops, Chiapasco, Ghisolfi, & Vogel, 2007; 
Schwarz, Bieling, Latz, Nuesry, & Becker, 2006; Schwarz, Claus, & 
Becker, 2017, Schwarz, John, & Becker, 2015, Schwarz et al., 2007, 
2017)
In addition to changes in bleeding on probing (BOP), probing 
depths (PD) and marginal bone levels (MBL), recent recommendations 
also underlined the need for the assessment of changes in peri-im-
plant soft tissue levels, which in turn may compromise the aesthetics 
at respective implant sites (Jepsen et al., 2019). In fact, based on a 
systematic review and meta-analysis evaluating a total of six studies 
(10 arms) focusing on augmentative therapy, the change in mucosal 
recession (MR) within a follow-up period of 12 months amounted 
to −0.7 mm (95% CI: −1.0/ −0.3) (Tomasi, Regidor, Ortiz-Vigón, & 
Derks, 2019). Apart from a surgical trauma, the occurrence of MR 
following therapy may also be attributed to a decrease in the horizon-
tal mucosal thickness resulting from a resolution of the inflammatory 
infiltrate at respective sites (Schwarz et al., 2017). Indeed, MR val-
ues were almost compensated when surgical therapy was combined 
with a simultaneous thickening of the mucoperiosteal flap by means 
of connective tissue grafts (Schwarz, Sahm, & Becker, 2014). At the 
time being, there are no data which may allow for a more in-depth 
evaluation of the dynamics of hard and soft tissue remodelling and 
maturation following surgical therapy of peri-implantitis.
Therefore, the present study aimed at evaluating the volumetric 
tissue changes at peri-implantitis sites following combined surgical 
therapy over a 6-month follow-up period.
2  | MATERIAL S AND METHODS
2.1 | Study design and participants
The present pilot study included patients who attended 
the Department of Oral Surgery and Implantology, Goethe 
University, Frankfurt, Germany, for the treatment of 
peri-implantitis.
All selected patients had received the same type of an estab-
lished and standardized surgical protocol during clinical routine 
treatments between March and June 2019.
Peri-implantitis was defined as the combination of BOP with 
or without suppuration, PD ≥ 6 mm and radiographic MBL (i.e. 
inter-proximal bone levels ≥3 mm apical of the most coronal 
portion of the intra-osseous part of the implant) (Berglundh 
et al., 2018). All included implants exhibited an intra-bony de-
fect component of ≥3 mm as detected on intra-oral radiographs, 
were clinically stable (i.e. no mobility at clinical examination) and 
were scheduled for a combined resective/augmentative surgical 
therapy.
Peri-implantitis severity was classified (i.e. slight, moderate and 
advanced) based on the evaluation of the defect length as measured 
from the implant neck and the ratio of MBL relative to the total im-
plant length (bone loss %) (Monje et al., 2019).
The study protocol (No. 92/19), considering the prospective 
assessment of clinical and volumetric outcomes of the selected 
patients over a period of 6 months, was approved by the ethics 
committee of the Goethe University, Frankfurt, Germany, and 
conducted in accordance with the Helsinki Declaration as revised 
in 2013. Each patient had received a detailed information of the 
study protocol and was required to sign an informed consent 
form.
The following report considers the checklist items of the STROBE 
statement.
K E Y W O R D S
dental implants, peri-implantitis, peri-implantitis therapy, three-dimensional analysis
Clinical Relevance
Scientific rationale of the study: Change in peri-implant hard 
and soft tissue levels is a critical outcome measure follow-
ing surgical therapy of peri-implantitis. The present study 
aimed at further analysing volumetric changes of peri-im-
plant tissues following a combined surgical therapy.
Principal findings: Peri-implant tissues underwent consid-
erable volumetric and soft tissue contour changes over a 
period of 6 months. The STCA contraction rate was signifi-
cantly correlated with KM width values at baseline (i.e. the 
lower the KM width, the higher the contraction rate).
Practical implications: The dimensional changes following 
combined surgical therapy of peri-implantitis are com-
monly associated with an aesthetic compromise at respec-
tive implant sites. These events may however be influenced 
by the pre-operative width of KM.
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2.2 | Inclusion criteria
The inclusion criteria for the selection of participants included the 
following: (a) minimum age of 18 years old, (b) titanium implants di-
agnosed with peri-implantitis requiring a combined surgical therapy, 
(c) implants presenting an intra-bony defect component of ≥3 mm 
as detected on radiographs, (d) implants with sufficient keratinized 
mucosa (KM) (i.e. ≥2 mm), (e) adequate oral hygiene as evidenced by 
a plaque index (PI) <1 (Löe, 1967), and (f) non-smokers and/or light 
smokers status (<10 cig/day).
2.3 | Exclusion criteria
The exclusion criteria considered patients who presented the follow-
ing: (a) general contraindications for oral surgical treatments, (b) un-
treated periodontal disease, (c) uncontrolled diabetes (HbA1c > 7), 
(d) pregnant or lactant women, and (e) autoimmune and/or inflam-
matory diseases affecting the oral cavity.
2.4 | Treatment procedures
All patients were subjected to pre-operative professional supra-
mucosal/gingival implant/tooth cleaning and underwent a sin-
gle episode of non-surgical therapy employing an Er:YAG laser 
(KEY3; KaVo, Biberach, Germany) (12.7 J/cm2). Subsequently, 
all patients had received the same type of an established and 
standardized surgical protocol during clinical routine treatments 
(Schwarz et al., 2014) provided by two experienced surgeons 
(K.O. and A.B.). Whenever possible, the prosthetic superstruc-
ture (i.e. screw-retained restorations and secondary compo-
nents) was removed to facilitate access and repositioned after 
the surgical procedure. Under local anaesthesia, full-thickness 
mucoperiosteal flaps were raised at vestibular and oral aspects. 
Subsequently, a meticulous and complete removal of granulation 
tissue was accomplished and the exposed implant surfaces were 
decontaminated using a titanium brush (Hans Korea Co., Ltd.). 
Implantoplasty was performed at buccally and/or supracrestally 
(if present) exposed implant surfaces using diamond burs (ZR 
Diamonds; Gebr. Brasseler GmbH & Co. KG) and Arkansas stones 
under copious irrigation with sterile saline. The intra-bony defect 
compartments were homogeneously filled using a natural bone 
mineral (Bio-Oss spongiosa granules, particle size 0.25–1 mm; 
Geistlich, Wolhusen, Switzerland) (NBM) and covered with a na-
tive collagen membrane (Bio-Gide; Geistlich). Mucoperiosteal 
flaps were repositioned and adapted using non-resorbable dou-
ble sutures. After 10 days of surgery, sutures were removed. All 
patients had received a perioperative one-shot antibiotic medica-
tion (2 g amoxicillin, oral) (Amoxicillin, Aliud Pharma, Laichingen, 
Germany) and supplementary daily mouthwash using 0.12% 
chlorhexidine digluconate solution (Corsodyl, GlaxoSmithKline 
Consumer Healthcare) for 5 days.
2.5 | Clinical examination
The following baseline clinical parameters were assessed as part 
of the clinical routine documentation at each implant site using 
a periodontal probe (PCP 12 Hu-Friedy Inc.): (1) KM width, (2) 
BOP, evaluated as present if bleeding was evident within 30 s 
after probing, or absent, if no bleeding was noticed within 30 s 
after probing, (3) PD as measured from the mucosal margin to the 
bottom of the probable pocket, (4) plaque index (PI) (Löe, 1967) 
and (5) MR measured from the implant shoulder/restoration mar-
gin to the mucosal margin, and suppuration, evaluated as positive 
if evident after probing. All measurements were performed at 6 
aspects per implant: mesio-vestibular, mid-vestibular, disto-ves-
tibular, mesio-oral, mid-oral and disto-oral by 2 calibrated inves-
tigators (K.O. and A.B.). PI, BOP, PD, MR and KM values were also 
assessed at 6 months. Prior to these measurements, both investi-
gators were calibrated by evaluating five patients, each present-
ing two implants with probing depths ≥4 mm and a radiographic 
MBL > 3 mm on at least one aspect, two times, with 48 hr apart. 
Calibration was accepted if repeated measurements were within a 
millimetre at >90% of the time.
Pre-operative MBL was assessed through radiological evalua-
tion using a software program (ImageJ, software, 1.52a, Maryland, 
USA). MBL linear measurements were performed by drawing a 
digital vertical line, following the long axis of the implant, from the 
implant shoulder to the bottom of the defect at distal and mesial 
sites. The numerical scale was set by means of the known implant 
length. Radiological measurements were performed by one exam-
iner (M.E.G.).
The assessment of the morphology and severity of peri-implan-
titis bone defects considered an established classification system 
(Monje et al., 2019).
2.6 | Outcome assessments
The primary endpoint was defined as the vestibular thickness 
change (mm) at respective implant sites following combined surgical 
therapy over a 6-month follow-up period. Thickness variations were 
evaluated at 1 (S1) and 6 (S2) months (Figure 1).
Secondary endpoints considered peri-implant soft tissue con-
tour area (STCA) changes (mm2) and the corresponding contraction 
rates (%), wound healing (wound infections (yes/no), changes in clini-
cal parameters (PI, BOP, PD, KM and MR values) and the association 
between baseline bone loss %, MR, as well as KM width and peri-im-
plant thickness and STCA changes at 6 months.
2.7 | Volumetric analysis
The region of interest (ROI) encompassing the peri-implantitis 
site was intra-orally scanned using an optical scanner (3 shape 
TRIOS MOVE, Germany GmbH) before surgery (S0), after 1 (S1) 
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and 6 months (S2) of the intervention as elucidated in Figure 1. 
To evaluate peri-implant volumetric changes, scanned files were 
converted to STL format. The pre-operative (S0) and postopera-
tive (S1, S2) STL files were aligned and superimposed by select-
ing 8 reproducible anatomical points in each computer aid design 
(CAD) body using a software program (Meshlab, ISTI, Italy, 2016). 
Thickness change computations between the corresponding time 
points (i.e. S0–S1 and S0–S2) were performed using a software 
program (GOM inspect 2018, Zeiss Company, Braunschweig, 
Germany) applying the CAD comparison tool (Figure 1b-a). A 
standardized ROI (per case) was delimited with a digital pen at 
the vestibular aspect. The ROI horizontal extension encompassed 
both adjacent papillae (mesial and distal), covering the crown/
abutment marginal contour and prolonging until the mid-marginal 
aspect of the contiguous teeth and/or implant. The ROI apical ex-
tension was determined by the known implant length (per case). 
The ROI was additionally subdivided into 3 vertically equidistant 
regions (i.e. marginal, medial and apical) for individual volumetric 
assessment (Figure 1b).
For STCA change analysis, digitalized scanned files correspond-
ing to S0, S1 and S2 time points were exported to an image analy-
sis software program (ImageJ, software, 1.52a, Maryland, USA). A 
F I G U R E  1   Schematic diagram 
exposing the stages of the study over 
a 6-month follow-up period. (a) STL 
files depict the study follow-up visits 
for the three-dimensional assessments. 
The standardized ROI encompassing 
the peri-implant area is enclosed by 
the red dotted line at S0, S1 and S2 
time points. (b) Superimposition of STL 
files showing volumetric changes. For 
individual thickness change analysis, the 
ROI was divided into three equidistant 
areas (marginal, medial and apical). (c) The 
superimposed files depict the thickness 
displacement at the mentioned regions. 
The colour scale bar shows thickness 
changes (mm) at the superimposed 
models, where negative values represent 
thickness gain and positive values 
represent loss. (d) Bar diagram depicts 
the assessed volumetric changes at the 
specific regions and follow-up periods. 
Post hoc Tukey's test p values are shown 
per region comparison, *p < .05 was 
considered statistically significant
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circumference of 15 mm diameter (having as a pivotal point the cen-
tral-vestibular aspect at the crown/abutment of each implant) was 
digitally traced. The STCA (within the mentioned circumference) 
was delineated with a digital pen and then its enclosed area was cal-
culated in mm2 (Figure 2a). The crown and/or abutment(s) width at 
each site served as reference to set up a numerical scale. STCA con-
traction rate (%) after 1 and 6 months of surgery was calculated ap-
plying the following formula: (S0- (evaluated time point)/ S0) × 100.
Each analysis was performed in triplicate by one calibrated ex-
aminer (M.E.G.).
2.8 | Statistical analysis
Mean values, standard deviations, medians and confidence intervals 
for primary and secondary outcomes were calculated using a com-
mercially available software program (SPSS, 19.0). Each implant was 
followed up with respect to the dimensional changes occurring over 
the 6-month follow-up; consequently, the implant site was defined 
as the statistical unit for primary outcome analysis. Shapiro–Wilk 
test was used to assume normality, considering p < .05 signifi-
cant. Assumption of homogeneity of variance was performed with 
F I G U R E  2   Demonstrative scan files 
depict (a) the delineated STCA perimeter 
before surgery (S0), after 1 (S1) and 6 (S2) 
months of surgery. The STCA changes in 
size and shape are exemplified in the blue 
regions with its corresponding surface 
areas (mm2). (b) The STCA contraction 
rate between the mentioned periods 
is portrayed on the bar diagram. Post 
hoc Tukey's test p values are shown per 
time comparison, p < .05 considered for 
statistical significance
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the Levene test, p < .05 significant. The paired t test and one-way 
ANOVA followed by post hoc Tukey's test were used to analyse 
clinical parameter changes before and after treatment, within-group 
changes as well as thickness and STCA changes over time. Linear 
regression analyses were performed to assess the relationship be-
tween the initial bone loss (%), MR, and KM width and thickness 
variations as well as the STCA changes at 6 months (S2). A value of 
p < .05 was considered statistically significant.
3  | RESULTS
The present analysis included 20 patients (9 males and 11 females) 
(mean age: 65 years; range: 53 to 79 years) exhibiting twenty-eight 
implants (mean function time: 10.5 years, SD: 5.8). Soft tissue heal-
ing was uneventful in all patients, and no implant loss was noted over 
the follow-up period. Four (20%) patients had a history of periodon-
tal disease and 5 (25%) reported to be light smokers (i.e. < 10 ciga-
rettes/day). All implants had a morse taper connection.
3.1 | Clinical assessments
Implant sites characteristics are presented in Table 1. Peri-implantitis 
severity, defect configuration classification and mean values for 
MBL and clinical parameters at baseline and after 6 months (i.e. clini-
cal parameters) are presented in Tables 2 and 3.
Mean PI was reduced by 0.05 (implant level) (p = .3) and 0.15 (pa-
tient level) (p = .35) revealing no statistical significance. Mean BOP 
scores were significantly decreased by 49% (implant level) (p < .001) 
and 53% (patient level) (p < .001), and mean PD values were also 
significantly reduced by 1.26 mm (implant level) (p < .001) and 
1.34 mm (patient level) (p < .001) at 6 months. MR values were signifi-
cantly increased by 0.61 mm (implant level) (p < .001) and 0.83 mm 
(patient level) (p < .001) following 6 months of surgery. Additionally, 
KM values were as well significantly decreased by 1.4 mm (p < .05) 
(implant and patient level) over the follow-up period.
3.2 | Dimensional assessments
Peri-implant tissues exposed a mean thickness change (loss) of −0.11 
(95% CI: −0.4 to 0.02) and −0.28 mm (95% CI: −0.8 to −0.4) after 1 
and 6 months following therapy, revealing a significant loss from S1 
to S2 (p = .013). S0 to S1 volumetric variations resulted in a thick-
ness change of −0.46 (95% CI: −0.5 to −0.3), 0.08 (95% CI: −0.1 
to 0.3) and 0.4 mm (95% CI: 0.2 to 0.6) at marginal, medial and api-
cal regions, respectively. Significant differences (post hoc Tukey's 
test) were noted between marginal and medial regions (p = .000), 
marginal and apical regions (p = .000), and medial and apical regions 
(p = .029), respectively.
S0 to S2 analysis resulted in a thickness change of −0.61 (95% 
CI: −0.8 to −0.4), −0.25 (95% CI: −0.4 to −0.1) and −0.09 (95% CI: 
−0.2 to 0.04) mm at marginal, medial and apical regions. Significant 
differences (post hoc Tukey's test) were noted between marginal 
and medial regions (p = .007), marginal and apical regions (p = .000), 
and medial and apical regions (p = .03), respectively. Accordingly, the 
thickness differences between the mentioned areas were statisti-
cally significant at both observational periods. Peri-implant volumet-
ric changes are depicted in Figure 1d.
The mean peri-implant STCA totalled to 189.2, 175 and 
158.9 mm2 at S0, S1 and S2, showing a significant STCA contraction 
rate of 7.9% (95% CI: 1 to 15.4) (post hoc Tukey's test) (p = .041) from 
TA B L E  1   Description of implant site characteristics and 
frequency distributions
Site characteristic
Number 
(n = 28)
Percentage 
(%)
Region
Anterior 6 21.4
Posterior 22 78.6
Jaw
Maxilla 14 50
Mandible 14 50
Bone grafted site
Yes
No 4 14.2
Bone grafting procedure (at implant 
placement)
24 85.8
External sinus floor elevation
Lateral ridge augmentation 2 50
Prosthesis type 2 50
Single 8 28.6
Multiple 20 71.4
TA B L E  2   Severity classification, defect configuration, mean 
MBL and bone loss% for peri-implantitis sites before surgical 
procedure, at the patient and implant levels
Implant level 
n = 28
Patient 
level n = 20
Severity (%)
Slight 14.3 15
Moderate 71.4 65
Advanced 14.3 20
Defect configuration (%)
Ib 3.4 –
Ic 25 –
Ie 14 –
Combined (suprabony and 
intra-bony components)
57.6 –
MBL (mm)a  3.35 ± 1.3 3.65 ± 1.2
Bone loss (%) (MBL/implant 
length)
37 ± 10 39 ± 12
aMarginal bone loss. 
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S0 to S1 and of 18.5% (95% CI: 11 to 25) from S0 to S2 (post hoc 
Tukey's test) (p = .000) as shown in Figure 2b.
Linear regression analysis revealed a statistically significant as-
sociation (coef = −0.074, R2 = .19, p = .018) between baseline KM 
width and STCA contraction rate (%) as exhibited in Figure 3, though 
the R2 value was low.
3.3 | Discussion
The present prospective study aimed at assessing volumetric tissue 
changes at peri-implantitis sites following combined surgical therapy. 
Within the limitations of a single-arm study, the three-dimensional 
analysis revealed that peri-implant tissues underwent considerable 
volumetric changes over a 6-month healing period. This was sup-
ported by the assessment of corresponding thickness and STCA 
alterations also pointing to significant dimensional variations, par-
ticularly at marginal regions after 1 and 6 months of healing.
To the authors’ knowledge, this is the first study evaluating vol-
umetric tissue changes at peri-implantitis sites following surgical 
therapy. A previous systematic review and meta-analysis evaluat-
ing the efficacy of augmentative therapy at peri-implantitis sites 
revealed that significant mucosal recessions (MR weighted mean 
difference = 0.7 mm) occurred over a 12-month follow-up period 
(Tomasi et al., 2019). Roos-Jansåker, Renvert, Lindahl, and Renvert 
(2007) reported in a case series assessing regenerative therapy 
(bovine-derived bone with a resorbable membrane employing 
submerged healing) at 16 peri-implant defects that MR changes 
amounted to −2.8 ± 1.4 mm after 1 year of treatment. Another 
case series evaluating two different regenerative approaches (i.e. 
application of nanocrystalline hydroxyapatite versus NBM in com-
bination with CM) at 20 intra-bony defects reported on lower MR 
values (i.e. −0.4 ± 0.2 and −0.3 ± 0.4 mm) over the same follow-up 
period (Schwarz et al., 2017). Moreover, a case series reporting on 
regenerative therapy using a combination of autogenous bone and 
a demineralized xenogenic bone graft at 36 peri-implantitis defects 
exhibited a MR that totalled to −1.3 ± 1 mm (Wiltfang et al., 2012), 
which were comparable to MR changes reported in other studies 
(Matarasso, Iorio Siciliano, Aglietta, Andreuccetti, & Salvi, 2014; 
Nart, de Tapia, Pujol, Pascual, & Valles, 2018). A randomized clin-
ical trial assessing the same combined surgical therapy (implanto-
plasty + NBM +CM) as used in the present study but comparing two 
different modalities for surface decontamination (i.e. Er:YAG laser 
versus plastic curettes + cotton pellets + sterile saline) indicated 
that MR values significantly increased by 0.5 ± 0.4 and 0.4 ± 0.2 mm 
at 12 months (Schwarz et al., 2012). Also, a prospective study as-
sessing the impact of the defect configuration on the clinical out-
come of regenerative therapy (NBM + CM) reported that all 27 
augmented defects subdivided into classes Ib (N = 9), Ic (N = 9) and 
Ie (N = 9), and exhibited MR changes of −0.4 ± 0.7, −0.5 ± 0.5 and 
−0.3 ± 0.6 mm at 12 months, respectively (Schwarz, Sahm, Schwarz, 
& Becker, 2010). Correspondingly, the reported outcomes are com-
parable with the present results indicating that the mean MR scores 
increased significantly by 0.61 ± 0.4 mm (implant level) following the 
mentioned combined surgical therapy (NBM + CM) over a 6-month 
follow-up period.
When further interpreting the results of the aforementioned 
studies, it must be kept in mind that MR values had been assessed 
in one dimension, and these changes may not necessarily corre-
spond to the volumetric outcomes noted in the present analysis. 
TA B L E  3   Clinical parameters (mean, SD and difference values) before surgical procedure and after 6-month follow-up, at the patient 
(n = 20) and implant levels (n = 28). *p < .05
Clinical parameter
Implant level 
baseline
Implant level 
6 months
Implant level 
difference
Patient level 
baseline
Patient level 
6 months
Patient level 
difference
PI (mean)a  0.5 ± 0.5 0.45 ± 0.6 0.05 ± 0.5 0.65 ± 0.5 0.5 ± 0.6 0.15 ± 0.5
0 (%) 50% 54.5% 4.5% 65% 50% 15%
1(%) 50% 45.4% 4.6% 35% 50% 15%
2(%) 0 0 0 0 0 0
3(%) 0 0 0 0 0 0
BOP (%)b  65 ± 35 16 ± 26 49 ± 25* 73 ± 33 20.5 ± 30 53 ± 28*
PD(mm)c  4.66 ± 1.4 3.4 ± 0.9 1.26 ± 1* 4.84 ± 1.4 3.5 ± 1.1 1.34 ± 1.1*
KM (mm)d  3.4 ± 1.3 2 ± 1.4 1.4 ± 1* 3.4 ± 1.4 2 ± 1.2 1.4 ± 1.2*
MR(mm)e  0.14 ± 0.3 0.75 ± 0.5 0.61 ± 0.4* 0.17 ± 0.34 1 ± 0.6 0.83 ± 0.4*
Suppuration (%)
Yes 39 0 39 55 0 55
No 61 0 61 45 0 61
aPlaque Index. 
bBleeding on Probing. 
cProbing depth. 
dKeratinized mucosa. 
eMucosal Recession. 
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Nevertheless, MR variations may be favoured by the thickness loss 
that had particularly occurred at the marginal regions after 1 and 
6 months of surgery. This loss in thickness may be mainly attributed 
to the resolution of the inflammatory infiltrate following therapy. In 
fact, a recent analysis evaluating the horizontal mucosal thickness 
(hMT) at healthy and diseased implant sites using a validated ultra-
sonic A-scanner pointed to a median hMT of 1.10 mm at healthy 
implant sites (Schwarz et al., 2017). These values were significantly 
lower at diseased sites, but similar for implants affected by peri-im-
plant mucositis and peri-implantitis (1.68 mm; 1.61 mm). Moreover, 
hMT values did not markedly differ by implant location (i.e. upper/
lower jaws) or position (i.e. anterior/posterior sites) and were also 
not correlated with PD values (Schwarz et al., 2017).
Even though the present analysis did not assess changes in 
hMT values, it is assumed that the marked clinical improvements in 
BOP values noted at 6 months following combined surgical therapy 
F I G U R E  3   Linear regression plots to represent the relationship between baseline bone loss (%) and (a) peri-implant tissue thickness 
change and (b) STCA (S0–S2), as well as baseline KM width (mm) and (c) peri-implant tissue thickness change and (d) STCA (S0–S2) and 
baseline MR (mm) and (e) peri-implant tissue thickness change and (f) STCA (S0–S2) at the implant level. p < .05 was considered statistically 
significant
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contributed to the noted marginal thickness changes. Previous clini-
cal data corroborate the clinical efficacy of this treatment approach, 
also reporting on mean BOP reductions of 47.8 ± 35.5 (Er:YAG laser 
decontamination) and 55.0 ± 31.1% (surface decontamination using 
plastic curettes + cotton pellets + sterile saline) at 6 months after 
therapy (Schwarz, Sahm, Iglhaut, & Becker, 2011). The biological 
principle that hMT may be linked with the occurrence of MR has 
also been demonstrated at healthy implant sites. In particular, after 
one year of functional loading, there was a significant difference in 
midfacial MR values noted between implant sites exhibiting either 
a thin or thick mucosal biotype (Mailoa et al., 2018). These poten-
tial correlations are also supported by previous findings of a case 
series evaluating the clinical outcome of a combined surgical ther-
apy of advanced peri-implantitis lesions with concomitant soft tis-
sue volume augmentation using connective tissue grafts (Schwarz 
et al., 2014). After 6 months of transmucosal healing, this surgical 
procedure was associated with a significant reduction in mean 
BOP (74.39 ± 28.52%) and PD (2.53 ± 1.80 mm) scores, which 
were associated with even slight increases in mean mucosal height 
(0.07 ± 0.5 mm) at the buccal aspects. A slight increase in mean MR 
was merely noted at two out of 13 implant sites, amounting to 0.3 
and 1.0 mm, respectively (Schwarz et al., 2014). The beneficial effect 
of a volume grafting procedure using connective tissue on peri-im-
plant soft tissue stability was also demonstrated when used along 
with open flap debridement alone (Dalago et al., 2019).
When further evaluating the present data, it was also noted that 
particularly the apical regions were initially (i.e. at 1 month) associ-
ated with a volume gain, which might be attributed to the grafting 
procedures performed at the intra-bony defect compartments. At 
6 months, however, the apical regions also revealed a thickness loss, 
most likely due to tissue remodelling and graft consolidation. The 
latter has been confirmed in a previous report on 5 human re-en-
try cases (Schwarz, John, & Becker, 2015). In particular, all patients 
had received a combined surgical treatment of peri-implantitis. The 
clinical defect resolution at the intra-bony component amounted to 
59.4% ± 47.59% pointing to a marked consolidation of the grafted 
area after healing periods of 8 months to 6.5 years (Schwarz, John, 
& Becker, 2015). In this context, it must be realized that the present 
volumetric analyses could not differentiate between soft and hard 
tissues, and therefore, potential differences in the wound healing 
dynamics at both compartments could not be investigated.
Another relevant finding of the present analysis was related to 
a significant STCA contraction rate of 18.5% over the 6-month fol-
low-up period, and this outcome links with the significant increase 
in MR values (measured in one dimensional assessments) reported in 
this study. The linear regression analyses pointed to a significant as-
sociation between baseline KM width values and STCA contraction 
rates, implying that peri-implantitis sites presenting a reduced KM 
width were more susceptible to the occurrence of MR following com-
bined surgical therapy. Still, this implication should be further evalu-
ated in future studies since this association reported a low R2 value. 
While a recent retrospective analysis indicated that the pre-oper-
ative width of KM (i.e. < and >2 mm) had no significant influence 
on the outcomes of either resective or augmentative treatments of 
peri-implantitis, its influence on MR changes had not been analysed 
(Ravida et al., 2020). Accordingly, the need to establish a certain 
width of KM to limit MR following surgical treatment of peri-implan-
titis needs to be further investigated (Sculean et al., 2019).
It is imperative to consider that the reliability of this novel 
method to evaluate thickness and STCA changes through the super-
imposition and analysis of scan files needs to be further assessed in 
future clinical investigations. Currently, this is the first study apply-
ing a 3-dimensional analysis to assess peri-implant tissue volumetric 
changes following peri-implantitis therapy; consequently, no data 
are available for comparison. Furthermore, future research should 
also consider larger sample sizes, longer follow-up periods and 
case–control study designs to bring more substantial information 
on volumetric tissue changes following combined surgical therapy 
of peri-implantitis.
Within its limitations, the present volumetric analysis suggests 
that the peri-implant tissues undergo considerable volumetric 
changes after combined surgical therapy. The tissue contraction, 
however, was influenced by the width of KM.
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